Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 333-338

  Martinez Pinna, R ^a   Lindholt, J S ^b   Blanco Colio, L M ^a   Dejouvencel, T ^c   Madrigal Matute, J ^a   Ramos Mozo, P ^a   Vega de Ceniga, M ^d   Michel, J B ^c   Egido, J ^a   Meilhac, O ^c   Martin Ventura, J L ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b VIBORG HOSPITAL   (Denmark)

^c INSERM   (France)

^d HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Abdominal aortic aneurysm; Biomarkers; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; THIOREDOXIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GROWTH RATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; WESTERN BLOTTING;

AGED; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CULTURE MEDIA, CONDITIONED; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; SPAIN; THIOREDOXINS; TISSUE CULTURE TECHNIQUES; UP-REGULATION;

EID: 77956228472     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.05.031     Document Type: Article

References (30)

1. Lindholt J.S., Jensen L.P. Vascular surgical procedures in Denmark 1996-2004 (Karkirurgiske procedurer i Danmark 1996-2004). Ugeskr Laeger 2007, 169:4066-4070.
2. Powell J.T., Brown L.C., Forbes J.F., et al. Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial. Br J Surg 2007, 94:702-708.
3. Baxter B.T., Terrin M.C., Dalman R.L. Medical management of small abdominal aortic aneurysms. Circulation 2008, 117:1883-1889.
4. Golledge J., Tsao P.S., Dalman R.L., Norman P.E. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008, 118:2382-2392.
5. Hokamaki J., Kawano H., Soejima H., et al. Plasma thioredoxin levels in patients with unstable angina. Int J Cardiol 2005, 99:225-231.
6. Miyamoto S., Sakamoto T., Soejima H., et al. Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction. Am Heart J 2003, 146:465-471.
7. Nishihira K., Yamashita A., Imamura T., et al. Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage. Atherosclerosis 2008, 201:360-367.
8. Caligiuri G., Rossignol P., Julia P., et al. Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2006, 26:618-623.
9. Lindholt J.S., Juul S., Fasting H., Henneberg E.W. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 2005, 330:750.
10. Lindholt J.S., Vammen S., Juul S., Henneberg E.W., Fasting H. The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 1999, 17:472-475.
11. Martin-Ventura J.L., Leclercq A., Blanco-Colio L.M., et al. Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. Atherosclerosis 2007, 194:334-341.
12. Michel J.B. Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction. Arterioscler Thromb Vasc Biol 2001, 21:1389-1392.
13. Fontaine V., Touat Z., Mtairag el M., et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol 2004, 164:2077-2087.
14. Cha M.K., Kim I.H. Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell. Biochem Biophys Res Commun 1995, 217:900-907.
15. Papalambros E., Sigala F., Georgopoulos S., et al. Malondialdehyde as an indicator of oxidative stress during abdominal aortic aneurysm repair. Angiology 2007, 58:477-482.
16. Miller F.J., Sharp W.J., Fang X., et al. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 2002, 22:560-565.
17. Liao M., Liu Z., Bao J., et al. A proteomic study of the aortic media in human thoracic aortic dissection: implication for oxidative stress. J Thorac Cardiovasc Surg 2008, 136:65-72. 72.e1-3.
18. Rubartelli A., Bajetto A., Allavena G., Wollman E., Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 1992, 267:24161-24164.
19. Soejima H., Suefuji H., Miyamoto S., et al. Increased plasma thioredoxin in patients with acute myocardial infarction. Clin Cardiol 2003, 26:583-587.
20. Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001, 286:2136-2142.
21. Nishiyama A., Ohno T., Iwata S., et al. Demonstration of the interaction of thioredoxin with p40phox, a phagocyte oxidase component, using a yeast two-hybrid system. Immunol Lett 1999, 68:155-159.
22. Trigona W.L., Mullarky I.K., Cao Y., Sordillo L.M. Thioredoxin reductase regulates the induction of hemo oxygenase-1 expression in aortic endothelial cells. Biochem J 2006, 394(Pt 1):207-216.
23. Billiet L., Furman C., Larigauderie G., et al. Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophages. J Biol Chem 2005, 280:40310-40318.
24. Tamaki H., Nakamura H., Nishio A., et al. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 2006, 131:1110-1121.
25. Pan J.H., Lindholt J.S., Sukhova G.K., et al. Macrophage migration inhibitory factor is associated with aneurysmal expansion. J Vasc Surg 2003, 37:628-635.
26. Nakamura H., Herzenberg L.A., Bai J., et al. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci USA 2001, 98:15143-15148.
27. Liu W., Nakamura H., Shioji K., et al. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Circulation 2004, 110:1276-1283.
28. Sato A., Hoshino Y., Hara T., et al. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice. J Pharmacol Exp Ther 2008, 325:380-388.
29. Dai J., Louedec L., Philippe M., Michel J.B., Houard X. Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model. J Vasc Surg 2009, 49:719-727.
30. Lindholt J.S., Sorensen H.T., Michel J.B., Thomsen H.F., Henneberg E.W. Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms. Vasc Endovascular Surg 2008, 42:329-334.